Does adherence to antihypertensive drug therapy reduce cardiovascular morbidity and mortality in patients aged 85 years or older?
Adherence to antihypertensive therapy remains beneficial for reducing cardiovascular morbidity and mortality even in very elderly patients (≥85 years).
Adherence with antihypertensive drug therapy reduced the risk of cardiovascular morbidity in patients aged 85 years or more, the benefit including heart failure and stroke, although not MI, and extending to all-cause death.
Corrao et al. (Sat,) studied this question.